Aurobindo Pharma Ltd's market cap is currently ₹630.26B. The company's EPS TTM is ₹14.2; its P/E ratio is 18.58; and it has a dividend yield of 0.36%. Aurobindo Pharma Ltd is scheduled to report earnings on August 4, 2025, and the estimated EPS forecast is ₹15.24. See an overview of income statement, balance sheet, and cash flow financials.
